Proteomics

Dataset Information

0

LC-MS/MS analysis of soluble lysosomal enzymes


ABSTRACT: Mucolipidosis III gamma (MLIII) is clinically characterized by onset of first symptoms at an average of 5 years such as stiffness of hands and shoulders, claw hand deformities, scoliosis and progressive destruction of hip joints. The disease is caused by mutations in GNPTG encoding the gamma-subunit of the GlcNAc-1-phosphotransferase complex. This enzyme is responsible for the generation of mannose 6-phosphate (M6P) targeting signals on 70 soluble lysosomal enzymes that are required for their efficient receptor-mediated transport to lysosomes. Complementary SILAC-based lysosomal proteomics revealed decreased amounts of several lysosomal enzymes in Gnptg-KO fibroblasts involved in the degradation of lipids, glycans and proteins.

INSTRUMENT(S): LTQ Orbitrap, LTQ Orbitrap Velos

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Fibroblast

DISEASE(S): Disease Free

SUBMITTER: Melanie Thelen  

LAB HEAD: Sandra Pohl

PROVIDER: PXD007547 | Pride | 2018-06-07

REPOSITORIES: Pride

Similar Datasets

2018-06-06 | PXD007546 | Pride
2018-06-06 | PXD009621 | Pride
2012-07-04 | E-MEXP-3505 | biostudies-arrayexpress
2012-07-04 | E-MEXP-3504 | biostudies-arrayexpress
2008-11-23 | E-GEOD-11335 | biostudies-arrayexpress
2008-12-22 | E-GEOD-12721 | biostudies-arrayexpress
2008-11-23 | E-GEOD-11337 | biostudies-arrayexpress
2011-11-23 | E-GEOD-33935 | biostudies-arrayexpress
2021-09-23 | PXD027476 | Pride
2022-09-29 | PXD029659 | Pride